Naoya Hattori Selected Research

Naoya Hattori Research Topics

3	Neoplasms (Cancer) 04/2017 - 05/2012
2	Glioblastoma (Glioblastoma Multiforme) 04/2017 - 05/2012
2	Hypoxia (Hypoxemia) 04/2017 - 05/2012
2	Necrosis 05/2012 - 04/2011
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2004 - 11/2003
1	Alzheimer Disease (Alzheimer's Disease) 06/2020
1	Cognitive Dysfunction 06/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2017
1	Lymphoma (Lymphomas) 01/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016
1	Infections 07/2015
1	Neoplasm Metastasis (Metastasis) 05/2015
1	Lymphatic Metastasis 04/2015
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 01/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2012
1	Glioma (Gliomas) 05/2012
1	Glucose Intolerance 07/2011
1	Coronary Stenosis (Coronary Artery Stenosis) 07/2011
1	Brain Neoplasms (Brain Tumor) 04/2011
1	Contusions 05/2004
1	Coma (Comas) 11/2003
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2002
1	Diabetes Mellitus 07/2002

5	Glucose (Dextrose)FDA LinkGeneric 04/2017 - 11/2003
2	fluoromisonidazoleIBA 04/2017 - 05/2012
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2011 - 07/2002
2	AmmoniaIBA 07/2011 - 07/2002
1	Amyloid (Amyloid Fibrils)IBA 06/2020
1	Oxygen (Dioxygen)IBA 12/2017
1	GadoliniumIBA 04/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	vasectrin I (VS I)IBA 05/2015
1	Risedronic Acid (Actonel)FDA LinkGeneric 01/2015
1	tositumomab I-131 (Bexxar)FDA Link 12/2012
1	carbon-11 methionineIBA 04/2011
1	HexokinaseIBA 05/2004
1	Deferoxamine (Desferal)FDA LinkGeneric 07/2002
1	Nitrogen-13IBA 07/2002
1	Hydroxyl RadicalIBA 07/2002

1	Minimally Invasive Surgical Procedures 07/2015
1	Debridement 07/2015
1	Thyroidectomy 05/2015
1	Therapeutics 05/2015
1	Hyperbaric Oxygenation 01/2015
1	Radioimmunotherapy 12/2012
1	Radiotherapy 04/2011